肾移植后转换为贝拉西普的机会性感染风险
多中心队列纳入280例肾移植患者,转换为贝拉西普后34例(12.1%)发生42次机会性感染,平均在转换后10.8±11.3个月。累积暴露5128个月,发病率为0.008次/月暴露和9.8次/100人年,最常见为巨细胞病毒病和肺孢子菌肺炎。机会性感染导致9/34例死亡和4/34例移植物失功。
要点
- 转换为贝拉西普后机会性感染风险显著,需加强监测和预防。
- 巨细胞病毒病和肺孢子菌肺炎是最常见的机会性感染。
- 转换时eGFR<25 mL/min/1.73 m2和移植前使用免疫抑制剂与机会性感染发生相关。
核心结论
- 转换为贝拉西普后机会性感染风险显著,可能需要额外监测和预防治疗,尤其是肺孢子菌肺炎和巨细胞病毒病。
研究设计与样本
- 多中心队列研究,纳入280例肾移植患者,报告转换为贝拉西普后的机会性感染发生率。
主要发现
- 34例(12.1%)患者发生42次机会性感染,平均在转换后10.8±11.3个月。
- 累积贝拉西普暴露5128个月,机会性感染发病率为0.008次/月暴露和9.8次/100人年。
- 最常见机会性感染为巨细胞病毒病(18/42,42.9%)和肺孢子菌肺炎(12/42,28.6%)。
- 2例患者发生进行性多灶性白质脑病,2例发生脑EB病毒诱导的移植后淋巴增殖性疾病。
- 机会性感染导致9/34例(26.5%)死亡和4/34例(11.8%)移植物失功。
关键数值与推荐
- 多因素分析显示转换当日eGFR<25 mL/min/1.73 m2和移植前使用免疫抑制剂与机会性感染发生相关。
- 早期转换组(6个月内)感染相关住院率更高(24.1 vs 12.3/100人年,P=0.0007)。
- 早期转换组机会性感染率更高(13.2 vs 6.7/100人年,P=0.005)。
临床怎么用
- 转换贝拉西普后应加强机会性感染监测,尤其关注肺孢子菌肺炎和巨细胞病毒病。
- 对转换时eGFR<25 mL/min/1.73 m2或移植前使用免疫抑制剂的患者应警惕机会性感染。
- 早期转换(6个月内)患者感染风险更高,需更密切随访。
局限性
- 数据需在更大样本的病例对照研究中确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Belatacept (bela) rescue therapy seems to be a valuable option for calcineurin inhibitor chronic toxicity in kidney transplantation. Nevertheless, the risk of infection associated with bela is not well reported. METHODS: We report the rate of opportunistic infections (OPI) after a switch to bela in a multicentric cohort of 280 kidney transplant patients. RESULTS: Forty-two OPI occurred in 34 patients (12.1%), on average 10.8 ± 11.3 months after the switch. With a cumulative exposure of 5128 months of bela treatment, we found an incidence of 0.008 OPI/month of exposure, and 9.8 OPI/100 person-years. The most common OPI was cytomegalovirus (CMV) disease in 18/42 OPI (42.9%) and pneumocystis pneumonia in 12/42 OPI (28.6%). Two patients presented a progressive multifocal leucoencephalopathy and two patients developed a cerebral Epstein-Barr virus-induced post-transplant lymphoproliferative disease. OPI led to death in 9/34 patients (26.5%) and graft failure in 4/34 patients (11.8%). In multivariate analysis, estimated glomerular filtration rate <25/mL/min/1.73 m2 on the day of the switch and the use of immunosuppressive agents before transplantation were associated with the occurrence of OPI. We found a higher rate of infection-related hospitalization (24.1 versus 12.3/100 person-years, P = 0.0007) and also a higher rate of OPI (13.2 versus 6.7/100 person-years, P = 0.005) in the early conversion group (within 6 months). CONCLUSIONS: The risk of OPI is significant post-conversion to bela and may require additional monitoring and prophylactic therapy, particularly regarding pneumocystis pneumonia and CMV disease. These data need to be confirmed in a larger case-control study.
引用
- Bertrand D, Chavarot N, Gatault P, et al. Opportunistic infections after conversion to belatacept in kidney transplantation. Nephrol Dial Transplant. 2020. PMID: 32030416. doi:10.1093/ndt/gfz255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。